BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27188620)

  • 1. [Percutaneous coronary interventions : Use between 2004 and 2012 in Germany].
    Ohlmeier C; Czwikla J; Enders D; Mikolajczyk R; Blindt R; Horenkamp-Sonntag D; Linder R; Garbe E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Jun; 59(6):783-8. PubMed ID: 27188620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Temporal trends in the use of drug-eluting stents in German clinical practice].
    Klein B; Zahn R; Heer T; Hochadel M; Tebbe U; Darius H; Kerber S; Schumacher B; Grube E; Hauptmann KE; Glunz HG; Senges J; Zeymer U
    Herz; 2008 Sep; 33(6):450-4. PubMed ID: 19156380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
    Onuma Y; Kukreja N; Daemen J; Garcia-Garcia HM; Gonzalo N; Cheng JM; van Twisk PH; van Domburg R; Serruys PW;
    JACC Cardiovasc Interv; 2009 Jul; 2(7):603-10. PubMed ID: 19628181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to use of radial access for percutaneous coronary intervention.
    Riangwiwat T; Mumtaz T; Blankenship JC
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):268-273. PubMed ID: 31797564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopharmacological Prescriptions in Children and Adolescents in Germany.
    Abbas S; Ihle P; Adler JB; Engel S; Günster C; Linder R; Lehmkuhl G; Schübert I
    Dtsch Arztebl Int; 2016 Jun; 113(22-23):396-403. PubMed ID: 27374377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous Coronary Intervention in Patients With End-Stage Liver Disease.
    Singh V; Patel NJ; Rodriguez AP; Shantha G; Arora S; Deshmukh A; Cohen MG; Grines C; De Marchena E; Badheka A; Ghatak A
    Am J Cardiol; 2016 Jun; 117(11):1729-34. PubMed ID: 27103158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating methods for intersectoral comparison of quality of care. A routine data analysis of elective percutaneous coronary interventions.
    Ohlmeier C; Linder R; Enders D; Mikolajczyk R; Haverkamp W; Horenkamp-Sonntag D; Garbe E
    Methods Inf Med; 2014; 53(4):269-77. PubMed ID: 25077437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional and hospital variations in the extent of decline in the proportion of percutaneous coronary interventions performed for nonacute indications - a nationwide population-based study.
    Liang FW; Lu TH; Wu HM; Lee JC; Yin WH
    BMC Cardiovasc Disord; 2017 Jun; 17(1):149. PubMed ID: 28599642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous coronary intervention for acute coronary syndrome due to graft failure: use of bare-metal and drug-eluting stents and subsequent long-term clinical outcome.
    Harskamp RE; Kuijt WJ; Damman P; Beijk MA; Grundeken MJ; Woudstra P; Tijssen JG; de Winter RJ
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):203-9. PubMed ID: 22508617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of percutaneous coronary intervention for the management of acute coronary syndromes and stable coronary artery disease in the United States (2007 to 2011).
    Kim LK; Feldman DN; Swaminathan RV; Minutello RM; Chanin J; Yang DC; Lee MK; Charitakis K; Shah A; Kaple RK; Bergman G; Singh H; Wong SC
    Am J Cardiol; 2014 Oct; 114(7):1003-10. PubMed ID: 25118124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.
    Tada T; Byrne RA; Simunovic I; King LA; Cassese S; Joner M; Fusaro M; Schneider S; Schulz S; Ibrahim T; Ott I; Massberg S; Laugwitz KL; Kastrati A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1267-74. PubMed ID: 24355117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal trends and patterns in percutaneous treatment of coronary artery disease in Poland in the years 2005-2011.
    Siudak Z; Ochała A; Lesiak M; Witkowski A; Gil RJ; Legutko J; Maciejewski P; Fijorek K; Dudek D
    Kardiol Pol; 2015; 73(7):485-92. PubMed ID: 25733178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender disparity in the use of drug-eluting stents during percutaneous coronary intervention for acute myocardial infarction.
    Iyanoye A; Moreyra AE; Swerdel JN; Gandhi SK; Cabrera J; Cosgrove NM; Kostis JB;
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):221-8. PubMed ID: 25645156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Which non-clinical factors influence the use of innovative implants? The example of drug-releasing coronary stents in patients with acute myocardial infarction: a multilevel regression analysis].
    Bäumler M
    Gesundheitswesen; 2013 Dec; 75(12):822-31. PubMed ID: 23868646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low rates of complications for carotid artery stenting are associated with a high clinician volume of carotid artery stenting and aortic endografting but not with a high volume of percutaneous coronary interventions.
    Modrall JG; Chung J; Kirkwood ML; Baig MS; Tsai SX; Timaran CH; Valentine RJ; Rosero EB
    J Vasc Surg; 2014 Jul; 60(1):70-6. PubMed ID: 24657297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short and long term outcome of percutaneous coronary intervention with drug eluting stent and bare metal stent in patients with chronic kidney disease.
    Resmini C; Di Cuia M; Ballocca F; D'Ascenzo F; Bollati M; Moretti C; Omedè PL; Sciuto F; Gaita F; Sheiban I
    Minerva Cardioangiol; 2012 Dec; 60(6):573-80. PubMed ID: 23147435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriateness of Percutaneous Coronary Interventions in Patients With Stable Coronary Artery Disease in US Department of Veterans Affairs Hospitals From 2013 to 2015.
    Hess PL; Kini V; Liu W; Roldan P; Autruong P; Grunwald GK; O'Donnell C; Doll JA; Ho PM; Bradley SM
    JAMA Netw Open; 2020 Apr; 3(4):e203144. PubMed ID: 32315067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
    Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
    Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.